| [1] |
Yang Jinqiang, Zhang Renmin.
Prognostic value of procalcitonin to platelet ratio in patients with fever with thrombocytopenia syndrome
[J]. Clinical Focus, 2023, 38(4): 346-351.
|
| [2] |
Liang Bingsong, Li Yuying, Zhang Qiping, Chen Yingdao, Li jian.
Analysis of factors affecting clinical efficacy of Tirofiban in treating branch atheromatous disease
[J]. Clinical Focus, 2023, 38(12): 1091-1094.
|
| [3] |
Qin Meijie, Tian Maolu, Yang Yuqi, Zha Yan, Yuan Jing.
Literature review on treatment of immune thrombocytopenia secondary to refractory systemic lupus erythematosus with belimumab combined with cyclosporine: A case report and literature review
[J]. Clinical Focus, 2022, 37(6): 544-547.
|
| [4] |
Wu Qiong, Sun Feng, Zhang Kai, Wang Zhiyi, Zhang Nana, Cheng Hui, Xiang Yang, Chang Xiaohui.
Curative effect of combination of eltrombopag and low-dose prednisone on refractory and relapsed primary immune thrombocytopenia in elderly patients
[J]. Clinical Focus, 2022, 37(11): 1008-1011.
|
| [5] |
Liu Yuanliang, Li Biao, Jiang Zuofeng, Zhu Youfeng, Zhang Shaoheng, Wang Yarong, Li Rongseng, Li Li.
Efficacy and safety of half-dose versus standard-dose of tirofiban for percutaneous coronary intervention in elderly Chinese patients with acute coronary syndrome: a meta-analysis
[J]. Clinical Focus, 2021, 36(11): 965-971.
|
| [6] |
Fu Haixia.
Study on standardized diagnosis and treatment of primary immune thrombocytopenia
[J]. Clinical Focus, 2021, 36(10): 896-900.
|
| [7] |
Hu Yangfan, Chen Xianrui, Shi Huixuan, Huang Jianqi.
Diagnostic value of absolute lymphocyte count for chronic primary immune thrombocytopenia in children：a meta analysis
[J]. Clinical Focus, 2020, 35(6): 492-497.
|
| [8] |
Li Yaopeng, Zhao Xing, Zhu Xiaolin.
Systematic review of tirofiban in the treatment of acute ischemic stroke
[J]. Clinical Focus, 2020, 35(5): 404-407.
|
| [9] |
Li Jiuquan.
Clinical study of tirofiban in acute stage of reocclusion after intravenous thrombolysis in perforating arterial cerebral infarction
[J]. Clinical Focus, 2019, 34(5): 420-422.
|
| [10] |
Yan Chaoqi1， Leng Qing1， You Guoping2， Zhang Lijun3.
Meta analysis of short term efficacy and side effects of eltrombopag in the treatment of adult idiopathic thrombocytopenic purpura
[J]. Clinical Focus, 2018, 33(9): 800-804.
|
| [11] |
Li Changqing1,2， Chai Erqing2， Jiang Lei1.
Efficacy and safety of tirofiban in mechanical thrombectomy for acute ischemic stroke
[J]. Clinical Focus, 2018, 33(9): 787-791,795.
|
| [12] |
Jing Hongfei， Wang Yanfang， Wang Long.
Safety and efficacy of urokinase plus tirofiban in treatment of acute ischemic stroke patients
[J]. Clinical Focus, 2018, 33(5): 409-412.
|
| [13] |
Chang Yingjun， Zhang Yuanyuan.
Progress on treatment of hematological disease in 2016
[J]. Clinical Focus, 2017, 32(2): 102-106.
|
| [14] |
Wei Yunxia;Cui Wei;Xie Ruiqin;Gu Guoqiang;Yang Xiaohong;Zheng Hongmei;Zhang Jidong;Zhang Guangming.
Incidence and risk factors of thrombocytopenia associated with tirofiban
[J]. Clinical Focus, 2015, 30(4): 367-371.
|
| [15] |
PENG Jun.
Advances in the treatment of refractory/relapsed immune thrombocytopenia
[J]. Clinical Focus, 2014, 29(10): 1091-1094.
|
